New York BRANY power

Group wins more clinical studies for local institutions, with benefits beyond the Hudson

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

An alliance of clinical institutions in New York City has attracted clinical studies and research dollars to the numerous medical schools and hospitals in the city, according to the group's president. Opportunities are up, and start-up time is down. But the group has also benefited other research facilities around the country and now has more than 100 affiliates in 18 states.

In the late 1990s, officials at the New York Academy of Medicine had noticed that the number of clinical trials taking place in New York City had dropped from a decade earlier. Although there were many reasons for the decline, one of the main ones was that bureaucratic issues at academic institutions had delayed projects from starting and had discouraged sponsors from future collaborations. In response, the academy, along with five New York City–area institutions, formed the Biomedical Research Alliance of New York (BRANY) in 1998.

Since then, BRANY ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Edward Winnick

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours